Raymond James & Associates’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$299K Buy
13,046
+1,769
+16% +$50.1K ﹤0.01% 3405
2024
Q2
$326K Sell
11,277
-5,865
-34% -$137K ﹤0.01% 3332
2024
Q1
$354K Sell
17,142
-94,604
-85% -$2.03M ﹤0.01% 3286
2023
Q4
$3.02M Sell
111,746
-22,416
-17% -$588K ﹤0.01% 1839
2023
Q3
$3.98M Buy
134,162
+9,770
+8% +$344K ﹤0.01% 1608
2023
Q2
$4.45M Sell
124,392
-3,996
-3% -$115K ﹤0.01% 1557
2023
Q1
$3.01M Sell
128,388
-3,076
-2% -$87.9K ﹤0.01% 1798
2022
Q4
$3.58M Sell
131,464
-19,888
-13% -$910K ﹤0.01% 1649
2022
Q3
$8.15M Sell
151,352
-6,572
-4% -$337K 0.01% 1072
2022
Q2
$6.37M Sell
157,924
-7,817
-5% -$387K 0.01% 1244
2022
Q1
$11M Sell
165,741
-25,254
-13% -$1.73M 0.01% 1013
2021
Q4
$19.1M Sell
190,995
-8,772
-4% -$907K 0.02% 769
2021
Q3
$25M Buy
199,767
+6,064
+3% +$720K 0.02% 594
2021
Q2
$24.1M Sell
193,703
-3,177
-2% -$427K 0.02% 624
2021
Q1
$30.1M Sell
196,880
-12,573
-6% -$1.9M 0.03% 484
2020
Q4
$27M Sell
209,453
-1,956
-0.9% -$225K 0.03% 489
2020
Q3
$23.6M Sell
211,409
-48,208
-19% -$4.41M 0.03% 475
2020
Q2
$21.1M Buy
259,617
+3,918
+2% +$316K 0.03% 497
2020
Q1
$17.8M Buy
255,699
+189,906
+289% +$14.6M 0.03% 498
2019
Q4
$5.14M Buy
65,793
+12,423
+23% +$895K 0.01% 1225
2019
Q3
$3.41M Buy
53,370
+461
+0.9% +$40.6K ﹤0.01% 1469
2019
Q2
$4.57M Buy
52,909
+47,729
+921% +$3.65M 0.01% 1263
2019
Q1
$397K Buy
+5,180
New +$287K ﹤0.01% 2816

Other funds holding GH